What is the appropriate amoxicillin/clavulanate (Augmentin) dosing for acute otitis media in a 3‑year‑old child weighing 46 lb (≈21 kg)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Augmentin Dosing for Otitis Media in a 3-Year-Old, 46 Pounds

For a 3-year-old child weighing 46 pounds (21 kg) with acute otitis media, prescribe high-dose amoxicillin-clavulanate (Augmentin) at 90 mg/kg/day of the amoxicillin component, which equals approximately 1890 mg/day total, divided into two doses of 945 mg each (or practically, 1000 mg twice daily), for 10 days.

Dosing Calculation and Formulation

At 21 kg body weight:

  • Total daily dose: 90 mg/kg/day × 21 kg = 1890 mg amoxicillin per day
  • Per dose: 945 mg twice daily (can round to 1000 mg for practical dosing)
  • Duration: 10 days 1, 2

The high-dose formulation (90 mg/kg/day amoxicillin with 6.4 mg/kg/day clavulanate in 2 divided doses) is specifically recommended by the FDA-approved Augmentin ES-600 formulation 2. Using the ES-600 suspension (600 mg amoxicillin per 5 mL), this child would receive approximately 7.5 mL twice daily.

Why High-Dose Therapy

High-dose amoxicillin-clavulanate is the first-line treatment for this age group because:

  • This 3-year-old falls into the moderate-risk category where β-lactamase-producing Haemophilus influenzae and resistant Streptococcus pneumoniae are concerns 1
  • The 90 mg/kg/day dosing achieves middle ear fluid concentrations adequate to overcome penicillin-resistant S. pneumoniae (MICs up to 4 mcg/mL) 3, 4
  • Clinical studies demonstrate 98.4% bacteriologic eradication of S. pneumoniae and 92.6% eradication of H. influenzae with this regimen 2, 4

When Standard-Dose Would Be Insufficient

The standard lower dose (45 mg/kg/day) would not be appropriate here because:

  • Children under 5 years have higher rates of resistant pathogens 3
  • The clavulanate component (6.4 mg/kg/day) in the high-dose formulation adequately inhibits all β-lactamase-producing H. influenzae and M. catarrhalis 3, 1

Administration Details

  • Give at the start of meals to minimize gastrointestinal side effects and enhance clavulanate absorption 2
  • Shake suspension well before each dose
  • Refrigerate reconstituted suspension; stable for 10 days 2
  • The twice-daily dosing improves compliance compared to three-times-daily regimens while maintaining equivalent efficacy 5

Expected Clinical Response

  • Assess improvement within 48-72 hours 1
  • If no improvement or worsening occurs, consider treatment failure and switch to ceftriaxone (50 mg/kg IM/IV for 3 days) 1
  • Clinical success rates with this regimen are approximately 89-95% at end of therapy 2, 4

Common Pitfalls to Avoid

Do not substitute other Augmentin formulations for ES-600, as they contain different clavulanate concentrations and are not interchangeable 2. The 200 mg/5 mL suspension contains only 28.5 mg clavulanate per 5 mL, while ES-600 contains 42.9 mg per 5 mL—this difference is critical for adequate β-lactamase inhibition.

Do not use standard-dose amoxicillin alone (without clavulanate) in this age group unless the child has no risk factors (no recent antibiotics, no daycare attendance, fully immunized) 3, 1. This 3-year-old's age alone makes high-dose amoxicillin-clavulanate more appropriate than amoxicillin monotherapy.

The most common side effect is diarrhea (protocol-defined diarrhea occurs in 11-13% of patients), though this is generally mild and does not require discontinuation 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.